Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.60    -0.60 (-1.75%)
Bid:
33.60
Ask:
34.40
Spread: 0.80 (2.381%)
Market Cap: £24.67m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Director/PDMR Shareholding

30 Sep 2025 18:14

RNS Number : 4995B
Carclo plc
30 September 2025
 

30 September 2025

 

Carclo plc

 

Director/PDMR Shareholding

 

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

Carclo plc announces that on 29 September 2025, a conditional award over the company's ordinary shares of 5p each was granted under the terms of the Carclo plc Deferred Bonus Plan 2025 to a director/ person discharging managerial responsibility ("PDMR") as set out below.

 

Name

Status

No. of shares granted

Frank Doorenbosch

Executive director

208,537

 

The 2025 Deferred Bonus Plan provides that, in accordance with the company's Directors' Remuneration Policy approved by shareholders in 2025, up to 33% of any annual bonus earned by an Executive Director may be deferred into shares (a "Deferred Share Award"). This award represents a deferral in shares with a market value equal to 33% of the annual bonus earned by Frank Doorenbosch in respect of the financial year ended 31 March 2025. In calculating the number of ordinary shares over which the Award has been made, the Remuneration Committee has applied the middle market quotation per ordinary share at closing on the day prior to the Grant Date.

The normal vesting date for this Deferred Share Award will be 29 September 2027, subject to continued employment and to the extent permitted following any operation of the Company's Malus and Clawback Policy. No other performance conditions apply. Dividend equivalents will accrue on the Shares subject to the Award in respect of ordinary dividends declared during the deferral period, calculated on the basis of reinvestment, and will be delivered in cash upon vesting of the Award.

This announcement and the following disclosures are made in accordance with Article 19 of the UK Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Frank Doorenbosch

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Carclo plc

b)

LEI

21380078MEM399JPI956

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p

 

ISIN: GB0001751915

b)

Nature of the transaction

Grant of a conditional award of shares under the Carclo plc Deferred Bonus Plan 2025. Subject to continued employment and, to the extent applicable, the operation of the Company's Malus And Clawback Policy.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP Nil

208,537

d)

Aggregated information

- Aggregated volume

- Price

 

N/A (single transaction)

e)

Date of the transaction

29-09-2025

f) 

Place of the transaction

Outside a trading venue

 

About Carclo plc:

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Carclo Group is a global precision engineering group that designs, industrialises and manufactures highly reliable solutions for Life Sciences, Aerospace and Safety & Security markets, manufactured in-region, for region.

 

Enquiries:

Carclo plc +44 (0) 20 8685 0500

Ian Tichias - Chief Financial Officer

Gerhard du Plessis - Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDCXBXDGUG
Date   Source Headline
29th Apr 20264:59 pmRNSDirector Dealing – Late Notification
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 202610:34 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Update
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSHalf-year Financial Report
17th Nov 20257:00 amRNSNotice of Half Year Results
30th Sep 20256:20 pmRNSDirector/PDMR Shareholding
30th Sep 20256:14 pmRNSDirector/PDMR Shareholding
26th Sep 202512:30 pmRNSResult of AGM
26th Sep 20257:00 amRNSTrading Update
19th Sep 20255:58 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSChange of Auditor
11th Sep 20258:41 amRNSDirector/PDMR Shareholding
1st Sep 20257:30 amRNSRestoration - Carclo PLC
29th Aug 202511:55 amRNSNotice of AGM
29th Aug 20257:00 amRNSFull Year 2025 audited results
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
1st Aug 20257:30 amRNSSuspension - Carclo PLC
17th Jul 20254:42 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSContract renewal strengthens revenue visibility
10th Jul 20257:00 amRNSTrading Statement & Delay in 2025 Audited Results
2nd May 202511:33 amRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Statement
28th Apr 20255:06 pmRNSHolding(s) in Company
24th Apr 20254:02 pmRNSRefinancing Arrangements, Pension Scheme Valuation
3rd Apr 20257:00 amRNSHolding(s) in Company
6th Mar 202510:43 amRNSHolding(s) in Company
18th Feb 20255:10 pmRNSHolding(s) in Company
13th Feb 20257:00 amRNSCFO Appointment
19th Dec 20243:49 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSInterim Report and Accounts 30 September 2024
12th Nov 202411:11 amRNSNotice of Interim Results & Investor Presentation
10th Sep 20249:33 amRNSHolding(s) in Company
5th Sep 20241:30 pmRNSResult of AGM
5th Sep 20247:00 amRNSTrading Update
16th Aug 202412:32 pmRNSHolding(s) in Company
5th Aug 202412:11 pmRNSHolding(s) in Company
31st Jul 202410:00 amRNS2024 Annual Report & Accounts and Notice of AGM
30th Jul 20243:21 pmRNSHolding(s) in Company
24th Jul 20242:49 pmRNSHolding(s) in Company
24th Jul 202412:57 pmRNSHolding(s) in Company
23rd Jul 20243:48 pmRNSHolding(s) in Company
23rd Jul 20241:08 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSFinal Results
17th Jul 20241:07 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNotice of Results
8th Jul 20248:51 amRNSBank Facilities Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.